SONX.D Stock Overview
A commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Sonendo, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.52 |
| 52 Week High | US$80.00 |
| 52 Week Low | US$1.00 |
| Beta | 1.48 |
| 11 Month Change | -64.83% |
| 3 Month Change | -74.88% |
| 1 Year Change | -82.60% |
| 33 Year Change | -99.82% |
| 5 Year Change | n/a |
| Change since IPO | -99.81% |
Recent News & Updates
Recent updates
Analysts Have Just Cut Their Sonendo, Inc. (NYSE:SONX) Revenue Estimates By 18%
Nov 10
A Piece Of The Puzzle Missing From Sonendo, Inc.'s (NYSE:SONX) Share Price
Apr 19Sonendo unit PIPStek files patent infringement lawsuit against Biolase
Jan 04GAAP EPS of -$0.47 misses by $0.08, revenue of $9.8M beats by $0.49M
Nov 09Sonendo announces $63 million private placement
Sep 23Sonendo: Painful Debut For This Dental Play
Nov 07Shareholder Returns
| SONX.D | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 65.1% | 0.9% | 2.2% |
| 1Y | -82.6% | 21.9% | 32.6% |
Return vs Industry: SONX.D underperformed the US Medical Equipment industry which returned 20.8% over the past year.
Return vs Market: SONX.D underperformed the US Market which returned 31.6% over the past year.
Price Volatility
| SONX.D volatility | |
|---|---|
| SONX.D Average Weekly Movement | 37.0% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SONX.D's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: SONX.D's weekly volatility has increased from 28% to 37% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 208 | Bjarne Bergheim | sonendo.com |
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system.
Sonendo, Inc. Fundamentals Summary
| SONX.D fundamental statistics | |
|---|---|
| Market cap | US$1.46m |
| Earnings (TTM) | -US$36.90m |
| Revenue (TTM) | US$41.66m |
0.0x
P/S Ratio0.0x
P/E RatioIs SONX.D overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SONX.D income statement (TTM) | |
|---|---|
| Revenue | US$41.66m |
| Cost of Revenue | US$24.60m |
| Gross Profit | US$17.06m |
| Other Expenses | US$53.96m |
| Earnings | -US$36.90m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -88.27 |
| Gross Margin | 40.94% |
| Net Profit Margin | -88.58% |
| Debt/Equity Ratio | 154.0% |
How did SONX.D perform over the long term?
See historical performance and comparison